Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

about

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

Item

http://www.wikidata.org/entity/Q58757059

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@en

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@nl

type

Item

label

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@en

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@nl

prefLabel

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@en

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@nl

P1476

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients

@en

P2860

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Influence of diabetes mellitus on the immunity to human tuberculosis.

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.

Diabetes and tuberculosis: a review of the role of optimal glycemic control.

Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.

Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.

A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?

Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.

Metformin as adjunct antituberculosis therapy.

P304

264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/JCM7090264

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chin-Hsiao Tseng

P577

2018-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30205606

http://www.w3.org/2001/XMLSchema#string

P921

metformin

type-2 diabetes

P932

6162822

http://www.w3.org/2001/XMLSchema#string